Lmcg Investments LLC lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 3.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 106,727 shares of the company's stock after selling 3,907 shares during the quarter. Procter & Gamble comprises 1.1% of Lmcg Investments LLC's investment portfolio, making the stock its 25th biggest holding. Lmcg Investments LLC's holdings in Procter & Gamble were worth $17,004,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds also recently made changes to their positions in PG. Brighton Jones LLC boosted its position in shares of Procter & Gamble by 51.5% during the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company's stock worth $6,717,000 after purchasing an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. boosted its position in shares of Procter & Gamble by 10.6% during the 1st quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company's stock worth $493,000 after purchasing an additional 277 shares in the last quarter. GAMMA Investing LLC boosted its position in shares of Procter & Gamble by 22.4% during the 1st quarter. GAMMA Investing LLC now owns 46,658 shares of the company's stock worth $7,951,000 after purchasing an additional 8,537 shares in the last quarter. Compagnie Lombard Odier SCmA boosted its position in shares of Procter & Gamble by 2.5% during the 1st quarter. Compagnie Lombard Odier SCmA now owns 1,166,917 shares of the company's stock worth $198,866,000 after purchasing an additional 28,605 shares in the last quarter. Finally, Rockland Trust Co. boosted its position in shares of Procter & Gamble by 6.4% during the 1st quarter. Rockland Trust Co. now owns 205,732 shares of the company's stock worth $35,061,000 after purchasing an additional 12,449 shares in the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Price Performance
Procter & Gamble stock opened at $149.69 on Friday. Procter & Gamble Company has a 52 week low of $149.45 and a 52 week high of $180.43. The company's 50 day moving average price is $155.24 and its two-hundred day moving average price is $159.53. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49. The stock has a market cap of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.99 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. During the same quarter last year, the firm earned $1.40 EPS. The company's quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Analysts Set New Price Targets
Several brokerages have recently commented on PG. Berenberg Bank increased their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a "hold" rating in a research note on Wednesday, September 17th. Wells Fargo & Company lowered their price objective on Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research note on Thursday, September 25th. JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a research note on Friday. UBS Group lowered their price objective on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, BNP Paribas Exane lowered their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating for the company in a research note on Tuesday, September 23rd. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $172.21.
Check Out Our Latest Stock Analysis on PG
Insider Buying and Selling
In related news, CEO Jennifer L. Davis sold 3,227 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $491,246.21. Following the sale, the chief executive officer owned 61,764 shares of the company's stock, valued at approximately $9,402,333.72. The trade was a 4.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Jon R. Moeller sold 11,684 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares in the company, valued at $48,703,248.36. This trade represents a 3.52% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 149,763 shares of company stock worth $23,421,279 in the last three months. Insiders own 0.20% of the company's stock.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.